Bayer HealthCare (BAY) to Present Data on Multiple Oncology Compounds at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013
9/17/2013 11:12:51 AM
WHIPPANY, N.J., Sept. 17, 2013 /PRNewswire/ -- Bayer HealthCare announced today that data from the company's oncology portfolio, including Nexavar® (sorafenib) tablets, Stivarga® (regorafenib) tablets and Xofigo® (radium Ra 223 dichloride) injection will be presented at the 2013 European Cancer Congress (ECCO/ESMO/ESTRO), September 28 – October 1, in Amsterdam, Netherlands.
Help employers find you! Check out all the jobs and post your resume.
comments powered by